Bluebird Bio reports positive early safety data from Ph I CAR-T trial
Bluebird Bio has reported encouraging efficacy and safety data from a Phase I trial of its CAR-T multiple myeloma therapy, bb2121.
Archives for December 2, 2016
Ita-leave? Italian referendum may impact European API supply chain
A ‘no’ vote in the Italian constitutional referendum this weekend may hurt the country's API industry and impact European drug supply chains.
Arrowhead fires CSO & Co-inventor of delivery tech responsible for clinical trial abandonment
Arrowhead Pharmaceuticals Inc. has also laid off its Chief scientific officer David Lewis - as part of the 34 staff cull - after several trials using delivery vehicle Ex1 were stopped by the firm.